New medical technology regulations from the European Union, Canada, and the United States are being implemented simultaneously, and they will impact companies’ bottom lines.
Additionally, the fast evolving EHS regulatory landscape related to chemical substances poses challenges to all manufacturers that need to keep track of substances that are ending up in their products.
Medical device manufacturers, while being faced with some new challenges, are also positioned with enhanced opportunities to develop new and innovative strategies that will allow them to thrive in the new and rapidly changing regulatory environment. The key is to be prepared, aware, and to think ahead.